CR Medicon

What CR Medicon does

CR Medicon is a privately held, for-profit clinical development Contract Research Organization (CRO) founded in 2017 and headquartered in Piscataway, United States. Its service portfolio spans four core capabilities: clinical data management, statistical analysis, statistical programming, and biological sample analysis — positioning it as a back-to-mid-clinical-trial services provider rather than a full-service CRO covering site management, monitoring, or regulatory affairs. The company operates at meaningful scale, with a headcount band of 1,001–5,000 employees.

The company's service stack addresses the analytical and laboratory back-end of clinical development, supporting sponsors (pharmaceutical, biotech, or academic) that require outsourced biostatistics, clinical database build/clean, and biospecimen work. No product names, technology platforms, proprietary tooling, or integrations are disclosed in the available source material. The corporate website at en.crmedicon.com currently renders only a loading/verification interstitial and provides no additional product, team, or capability detail, leaving technology architecture unverified.

CR Medicon's revenue model and GTM motion are not documented. There is no disclosed pricing model (time-and-materials vs. fixed-fee vs. FTE-based), no named customer logos, no contract-value benchmarks, and no segment mix (large pharma vs. mid-biotech vs. academic). Funding history is absent; no investors, rounds, or capital raised are reported. The company is private, non-listed, and has no disclosed parent, subsidiaries, or M&A history. Operating geographies beyond the U.S. headquarters are not enumerated.

Name

CR Medicon

Website

https://en.crmedicon.com

Company type

Private

Founded year

2017

Headcount range

101–250 employees

Short description

CR Medicon is a U.S.-based clinical development CRO, founded in 2017 and headquartered in Piscataway, providing data management, statistical analysis, programming, and biological sample analysis services to clinical trial sponsors at the 1,001–5,000 employee scale.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

Keywords

• Clinical research services
• Clinical data management
• Statistical analysis services
• Biological sample analysis
• Contract research organization

Headquarters

HQ city

Piscataway

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Core offering

CR Medicon is a clinical development Contract Research Organization (CRO) that delivers outsourced services including clinical data management, statistical analysis, programming, and biological sample analysis to drug development sponsors. The company supports clinical trial execution by managing study data, performing biostatistics, providing programming outputs, and conducting bioanalytical laboratory work on biological samples.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Data Management Outsourced clinical trial data management services for sponsors, covering the capture, cleaning, and validation of clinical study data across the trial lifecycle.
• Statistical Analysis Biostatistics services supporting clinical development, including the design and execution of statistical analyses required for clinical trial reporting and submissions.
• Clinical Programming Programming services producing datasets, tables, listings, and figures (TFLs) and other programming outputs used in clinical trial analysis and regulatory deliverables.
• Biological Sample Analysis Bioanalytical laboratory services analyzing biological samples collected during clinical trials, supporting pharmacokinetic, biomarker, and other clinical study assessments.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Parexel: Large global CRO with established biostatistics, data management, and clinical lab services; competes with CR Medicon in the same buyer pool of biopharma sponsors.
• ICON plc: Top-five global CRO providing full Phase I–IV services including data management, biostatistics, and lab services; competes with CR Medicon across nearly every service line but at much greater scale.
• Charles River Laboratories: Major preclinical and clinical CRO with significant bioanalytical and biostatistics capabilities; an established competitor for the bioanalysis/data portion of CR Medicon's offering.
• IQVIA: Largest global CRO with deep data, biostatistics, and laboratory capabilities; sets the competitive ceiling for clinical data services that CR Medicon also offers.

Emerging players

• Advanced Clinical: US-based mid-size CRO focused on clinical operations, data management, and biostatistics for emerging biotech sponsors — comparable in size and service profile.
• Cytel: Specialist biostatistics and data services provider to clinical trials; directly comparable to CR Medicon's data management and statistical programming capabilities.

Direct peers

• Worldwide Clinical Trials: Mid-tier global CRO offering clinical development, data management, biostatistics, and bioanalytical services — closely matches CR Medicon's stated service portfolio.
• Medpace: Mid-size, US-headquartered full-service clinical CRO with a strong biostatistics and data management practice; one of the most directly comparable peers in scale, geography, and service mix.

Regional players

• Tigermed (Hangzhou Tigermed): China-headquartered clinical CRO with growing US presence; directly competes for global clinical data management and biostatistics work, often at lower cost points.
• Novotech: Asia-Pacific-focused clinical CRO expanding into the US, with comparable data management and biostatistics services; competes for global study work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/CRMedicon
• Facebookfacebook.com/crmedicon

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CR Medicon